Skip to content
OpenCapital
Get started

Rapid Micro Biosystems RPID Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale at other companies

Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$48.25M-57.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$108.18M—
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Rapid Micro Biosystems (RPID) reported proceeds from maturities, prepayments and calls of debt securities, available-for-sale of $10M in Q1 2026.
How has Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale changed year-over-year?
Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale decreased by 9.1% year-over-year, from $11M to $10M.
What is the long-term trend for Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's proceeds from maturities, prepayments and calls of debt securities, available-for-sale has grown at a 27.6% compound annual growth rate (CAGR), from $15M to $39.75M.
What does proceeds from maturities, prepayments and calls of debt securities, available-for-sale mean?
This measures cash inflows resulting from the natural maturity or early redemption of debt securities held in the investment portfolio. It indicates the recurring cash generation from the company's fixed-income investment strategy.